MARKET

LIFE

LIFE

aTyr Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.856
-0.035
-0.89%
After Hours: 3.870 +0.015 +0.38% 19:01 09/23 EDT
OPEN
3.970
PREV CLOSE
3.890
HIGH
3.993
LOW
3.820
VOLUME
54.05K
TURNOVER
--
52 WEEK HIGH
7.62
52 WEEK LOW
2.130
MARKET CAP
38.33M
P/E (TTM)
-1.1225
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentationsNEW YORK, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the September 17th conference are now available
GlobeNewswire · 2d ago
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals
GlobeNewswire · 09/14 13:35
aTyr Pharma Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
Aspire Capital commits to purchase up to $20 Million of Common Stock over a period of up to 30 months.SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological
GlobeNewswire · 09/14 13:03
aTyr Pharma Announces $20M Stock Purchase Agreement From Aspire Capital; Set To Take Place Over Period Of Up To 30 Months
aTyr Pharma Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC Aspire Capital commits to purchase up to $20 Million of Common Stock over a period of up to 30 months. SAN
Benzinga · 09/14 12:15
aTyr pharma announces $20M common stock purchase agreement
aTyr Pharma (LIFE) enters into a common stock purchase agreement providing for the sale of up to $20M of common stock to Aspire Capital Fund, LLC. Aspire Capital has committed
Seekingalpha · 09/14 12:14
2 Conferences Are Going Virtual This Month – One On Cannabis And Another Life Sciences
The coronavirus pandemic has made this an interesting time for the cannabis and life sciences industries.
Benzinga · 09/08 16:12
aTyr Pharma to Present at Life Sciences Investor Forum on September 17th
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (the “Company”) (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive
GlobeNewswire · 09/02 11:00
Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential
The dog days of summer have come to a close, and investors want to know what the fall has in store for the market. August was kind to the stock market, with the S&P 500 gaining more than 7% in the month. This impressive performance marked the index’s best return for the month since 1984. But have stocks
TipRanks · 09/01 20:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LIFE. Analyze the recent business situations of aTyr Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LIFE stock price target is 13.33 with a high estimate of 15.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 44
Institutional Holdings: 6.24M
% Owned: 62.80%
Shares Outstanding: 9.94M
TypeInstitutionsShares
Increased
8
329.35K
New
10
47.97K
Decreased
4
30.80K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.78%
Pharmaceuticals & Medical Research
-1.14%
Key Executives
Chairman/Independent Director
John Clarke
President/Chief Executive Officer/Director
Sanjay Shukla
Chief Financial Officer
Jill Broadfoot
General Counsel/Secretary
Nancy Krueger
General Counsel/Secretary
Nancy Denyes
Independent Director
Timothy Coughlin
Independent Director
Jane Gross
Independent Director
Jeffrey Hatfield
Independent Director
Svetlana Lucas
Independent Director
Paul Schimmel
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About LIFE
aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based therapeutics for the treatment of rare diseases, including facioscapulohumeral muscular dystrophy (FSHD) and limb-girdle muscular dystrophy (LGMD) 2B. The Company is developing Resolaris, an intravenous protein therapeutic for the treatment of rare myopathies with an immune component (RMICs). The Company is investigating Resolaris in patients with LGMD2B. The Company is conducting approximately three open label trials in patients with early onset FSHD, in adult patients with FSHD or LGMD2B and a long-term extension study in adult patients with FSHD. The Company has not generated any revenues.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of aTyr Pharma Inc stock information, including NASDAQ:LIFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LIFE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LIFE stock methods without spending real money on the virtual paper trading platform.